Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Valuation
Trading at 12.3× sales vs its 22.4× historical median P/S.
Fair value ≈ $1.54 · price $0.84 today
Undervalued · 45% below
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$PETV Q4 '26 Earnings Results & Recap
PetVivo reported fiscal 2026 revenues of $1,141,607, a gross profit of $754,751, and an operating loss of $(9,062,962), resulting in a net loss per share of $(0.38) for the year ended March 31, 2026.
$PETV Check this out !!!
https://www.otcmarkets.com/stock/PETV/news/PetVivo-Holdings-Announces-Transformative-Acquisition-Of-PiezoBioMembrane-To-Build-a-Leading-Functional-Biomaterials-Pla?id=526042
Petvivo Holdings (OTCQX: $PETV ) brings its veterinary biotech platform for companion animals to the Life Sciences Virtual Investor Forum on June 24 at 12:00 PM ET.
PetVivo Holdings Inc (OTCQX: PETV) joins the Life Sciences Virtual Investor Forum, co-hosted by Virtual Investor Conferences and Zacks Small Cap Research, at 12:00 PM ET on Wednesday, June 24, 2026.
The Life Sciences Virtual Investor Forum is a B2i Digital Featured Conference. For more details, please visit: https://b2idigital.com/vic-june-25th-life-sciences-virtual-investor-forum
To register and view the presentation: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5396699/petvivo-holdings-inc-otcqx-petv?utm_source=b2i&utm_medium=marketing&utm_campaign=0624LifeSciencesForumVIC
Request a one-on-one meeting: https://app.axleaccess.com/public/events/636943bb-55cb-4a39-81b5-f658175de392?token=7b91921e-7b44-4da7-be93-ea5c37a5ed76
John Lai, CEO, President, and Director, presents for PetVivo. He has served as a senior executive of the company since 2014 and brings over thirty years of senior executive, operational management, and financial experience across several public companies.
PetVivo is a veterinary biotech and biomedical device company focused on translating human biotech and medical technology into products for the veterinary market, helping companion animals such as dogs and horses suffering from arthritis and other afflictions.
Learn more at https://www.petvivo.com/investors.
Virtual Investor Conferences is an OTC Markets Group Inc. property. Learn more at www.virtualinvestorconferences.com.
Discover more emerging growth Featured Companies, industry-leading Featured Experts, and upcoming Featured Conferences at https://b2idigital.com.
B2i Digital is the Official Marketing Partner of Virtual Investor Conferences. Content is informational only and is not investment advice. B2i Digital is not a broker-dealer or investment adviser.
